Hugo Biotech Raises ￥10M in Pre-A2 Financing

According to VCBeat, Hugo Biotech raised ￥10 million in Pre-A2 financing from TEB VC.

Hugo Biotech focuses on microbial sequencing and big data analysis in microbial genome. Adhering to independent innovation, the company cooperated with well-known microbial genomics experts in the United States in 2017 and took the lead in completing the clinical transformation of metagenomic NGS (mNGS) screening for pathogenic microorganisms. Hugo Biotech has conducted the sequencing of nearly 20,000 clinical samples for over 300 first-class hospitals in China.

At the very beginning of Hugo Biotech's establishment in 2017, Academician Chen Xinzi, a founder of TEB VC, began to pay attention to the company and provided crucial help and support for the company's development.

Academician Chen has been engaged in education and scientific research for many years. He was once the President of Hong Kong Baptist University. He attaches great importance to the transformation of scientific and technological achievements and the cultivation of innovative talents. Chen spoke highly of Xia Han, the founder of Hugo Biotech with his leadership in team building, the application of innovative technologies in clinical medicine, and the commercialization of products.

Chen believes that Hugo Biotech can give full play to its advantages in biological information and big data, and promote the application of metagenomics in the field of pathogenic microorganisms to the international leading level by cooperating with top microbiologists and algorithm team, so as to deal with unresolved clinical problems and benefit patients.

TEB VC is an international venture capital fund founded by Chen Xinzi (an academician of the Chinese Academy of Sciences) and Dr. Yang Denggui (a postdoc of MIT) in 2016. It mainly invests in pharmaceutical R&D, biopharmaceuticals, medical equipment, new materials in angel round. The company is committed to improving the efficiency of the transformation of scientific and technological achievements and advancing the development of emerging industries.